CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma

Cell Death and Differentiation

Volumn 22, Issue 7, 2015, Pages 1192-1202

  Teodorczyk, M ^a   Kleber, S ^a   Wollny, D ^a   Sefrin, J P ^a   Aykut, B ^a   Mateos, A ^a   Herhaus, P ^a   Sancho Martinez, I ^a,f   Hill, O ^b   Gieffers, C ^b   Sykora, J ^b   Weichert, W ^c   Eisen, C ^a,d   Trumpp, A ^a,d   Sprick, M R ^a,d   Bergmann, F ^c   Welsch, T ^e   Martin Villalba, A ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b APOGENIX GMBH   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Exp Hematology Group Heidelberg Institute for Stem Cell Technology and Experimental Medicine GGmbH   (Germany)

^e German Cancer Consortium ^*  (Germany)

^f SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MOLECULAR MARKER; FAS ANTIGEN; FAS PROTEIN, HUMAN; SHC SIGNALING ADAPTOR PROTEIN; SHC TRANSFORMING PROTEIN 2; SHC2 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CANCER PATIENT; CANCER STEM CELL; CELL CYCLE PROGRESSION; CELL MIGRATION; COMPUTER MODEL; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PANCREAS ADENOCARCINOMA; PANCREAS CELL; PRIMARY CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; DRUG SCREENING; FEMALE; METABOLISM; MOUSE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOPHYSIOLOGY; PHYSIOLOGY;

MURINAE;

ANIMALS; ANTIGENS, CD95; BIOMARKERS, TUMOR; CARCINOMA, PANCREATIC DUCTAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MICE; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; SHC SIGNALING ADAPTOR PROTEINS; SIGNAL TRANSDUCTION; SRC HOMOLOGY 2 DOMAIN-CONTAINING, TRANSFORMING PROTEIN 2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84930753559     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.217     Document Type: Article

References (45)

1. Visvader JE. Cells of origin in cancer. Nature 2011; 469: 314-322.
2. Sarkar B, Dosch J, Simeone DM. Cancer stem cells: a new theory regarding a timeless disease. Chem Rev 2009; 109: 3200-3208.
3. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V et al. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67: 1030-1037.
4. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. Cancer J Clin 2010; 60: 277-300.
5. De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013; 13: 97-110.
6. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
7. Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012; 148: 349-361.
8. Christofori G. New signals from the invasive front. Nat Cell Biol 2006; 441: 444-450.
9. Bivona TG, Hieronymus H, Parker J, Chang K, Taron M, Rosell R et al. FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR. Nature 2011; 471: 523-526.
10. Chen L, Park S-M, Tumanov AV, Hau A, Sawada K, Feig C et al. CD95 promotes tumour growth. Nature 2010; 465: 492-496.
11. Kleber S, Sancho-Martinez I, Wiestler B, Beisel A, Gieffers C, Hill O et al. Yes and PI3K Bind CD95 to signal invasion of glioblastoma. Cancer Cell 2008; 13: 235-248.
12. Sancho-Martinez I, Martin-Villalba A. Tyrosine phosphorylation and CD95: a FAScinating switch. Cell Cycle 2009; 8: 838-842.
13. Barnhart BC, Legembre P, Pietras E, Bubici C, Franzoso G, Peter ME. CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J 2004; 23: 3175-3185.
14. Desbarats J, Birge RB, Mimouni-Rongy M, Weinstein DE, Palerme J-S, Newell MK. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat Cell Biol 2003; 5: 118-125.
15. Corsini NS, Sancho-Martinez I, Laudenklos S, Glagow D, Kumar S, Letellier E et al. The death receptor CD95 activates adult neural stem cells for working memory formation and brain repair. Stem Cell 2009; 5: 178-190.
16. Letellier E, Kumar S, Sancho-Martinez I, Krauth S, Funke-Kaiser A, Laudenklos S et al. CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. Immunity 2010; 32: 240-252.
17. Badea L, Herlea V, Dima SO, Dumitrascu T, Popescu I. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 2008; 55: 2016-2027.
18. Collisson EA, Sadanandam A, Olson P, Gibb WJ, Truitt M, Gu S et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med 2011; 17: 500-503.
19. Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-273.
20. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
21. Anastassiou D, Rumjantseva V, Cheng W, Huang J, Canoll PD, Yamashiro DJ et al. Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo. BMC Cancer 2011; 11: 529.
22. Burstin von J, Eser S, Paul MC, Seidler B, Brandl M, Messer M et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. YGAST 2009; 137: 361-365.
23. Waerner T, Alacakaptan M, Tamir I, Oberauer R, Gal A, Brabletz T et al. ILEI: A cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell 2006; 10: 227-239.
24. Tuettenberg J, Seiz M, Debatin K-M, Hollburg W, Staden von M, Thiemann M et al. Pharmacokinetics, pharmacodynamics, safety and tolerability of APG101, a CD95-Fc fusion protein, in healthy volunteers and two glioma patients. Int Immunopharmacol 2012; 13: 93-100.
25. Satoh K, Shimosegawa T, Masamune A, Hirota M, Koizumi M, Toyota T. Fas ligand is frequently expressed in human pancreatic duct cell carcinoma. Pancreas 1999; 19: 339-345.
26. Senft J, Helfer B, Frisch SM. Caspase-8 Interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility. Cancer Res 2007; 67: 11505-11509.
27. Daigle I, Yousefi S, Colonna M, Green DR, Simon H-U. Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat Med 2002; 8: 61-67.
28. Martin-Villalba A, Llorens-Bobadilla E, Wollny D. CD95 in cancer: tool or target? Trends Mol Med 2013; 19: 329-335.
29. Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature 2004; 431: 405-406.
30. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med 2011; 17: 313-319.
31. Maenhaut C, Dumont JE, Roger PP, van Staveren WC. Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis. Carcinogenesis 2010; 31: 149-158.
32. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-892.
33. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013; 339: 580-584.
34. Cardone MH, Salvesen GS, Widmann C, Johnson G, Frisch SM. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 1997; 90: 315-323.
35. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995; 270: 7795-7798.
36. Desbarats J, Newell MK. Fas engagement accelerates liver regeneration after partial hepatectomy. Nat Med 2000; 6: 920-923.
37. Kim H-K, Jeong M-J, Kong M-Y, Han MY, Son K-H, Kim HM et al. Inhibition of Shc/Grb2 protein-protein interaction suppresses growth of B104-1-1 tumors xenografted in nude mice. Life Sci 2005; 78: 321-328.
38. APG101-CD-002: A phase II, randomized, open-label, multicenter study of weekly APG101 plus reirradiation versus reirradiation in the treatment of patients with recurrent glioblastoma. 2012 ASCO Annual Meeting Abstracts. Meeting Library. Available at: http://meetinglibrary.asco.org/content/97870-114 (last accessed 23 January 2014).
39. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M et al. NCBI GEO: archive for functional genomics data sets - update. Nucleic Acids Res 2012; 41: D991-D995.
40. cran.r-project.org. Available at: http://cran.r-project.org (last accessed 23 January 2014).
41. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article3.
42. Smyth GK. limma: Linear Models for Microarray Data. Springer: New York, NY, USA.
43. Muñoz J, Stange DE, Schepers AG, van de Wetering M, Koo B-K, Itzkovitz S et al. The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers. EMBO J 2012; 31: 3079-3091.
44. Flicek P, Ahmed I, Amode MR, Barrell D, Beal K, Brent S et al. Ensembl 2013. Nucleic Acids Res 2012; 41: D48-D55.
45. Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, Perez Alea M et al. Singlecell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA 2008; 105: 13427-13432.